Portfolio of Gene Editing (CRISPR) Stocks
Here are 4 gene editing stocks that use CRISPR technology.
| 4 Portfolio of Gene Editing (CRISPR) Stocks | ||
|---|---|---|
Name & Return | Symbol | |
| Crispr Therapeutics | CRSP | |
| Editas Medicine | EDIT | |
| Intellia Therapeutics | NTLA | |
| Vertex Pharmaceuticals | VRTX | |
| Display Price Chart for each stock. | ||
| Display Dividend Chart for each stock. | ||
Portfolio Values
To inspect the performance of the Portfolio of Gene Editing (CRISPR) Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.All 4 stocks are included in the portfolio computations. The current value of the portfolio assumes that $2,500.00 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.The current value of the $10,000 investment is $13,341. The percent return is 33.41%. The annualized return is 5.93%.
Related Portfolios
Portfolio of Genetic Testing Stocks